Biologic Drugs With Mechanism of Action: Neonatal Fc Receptor Blockers
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Neonatal Fc Receptor Blockers
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Argenx Bv | VYVGART | efgartigimod alfa-fcab | Injection | 761195 | 2021-12-17 | ⤷ Start Trial | ⤷ Start Trial |
| Ucb, Inc. | RYSTIGGO | rozanolixizumab-noli | Injection | 761286 | 2023-06-26 | ⤷ Start Trial | ⤷ Start Trial |
| Argenx Bv | VYVGART HYTRULO | efgartigimod alfa and hyaluronidase-qvfc | Injection | 761304 | 2023-06-20 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
